BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26045263)

  • 1. ATP8B1 and ATP11C: Two Lipid Flippases Important for Hepatocyte Function.
    Naik J; de Waart DR; Utsunomiya K; Duijst S; Mok KH; Oude Elferink RP; Bosma PJ; Paulusma CC
    Dig Dis; 2015; 33(3):314-8. PubMed ID: 26045263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired Hepatic Uptake by Organic Anion-Transporting Polypeptides Is Associated with Hyperbilirubinemia and Hypercholanemia in Atp11c Mutant Mice.
    Matsuzaka Y; Hayashi H; Kusuhara H
    Mol Pharmacol; 2015 Dec; 88(6):1085-92. PubMed ID: 26399598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes.
    de Waart DR; Naik J; Utsunomiya KS; Duijst S; Ho-Mok K; Bolier AR; Hiralall J; Bull LN; Bosma PJ; Oude Elferink RP; Paulusma CC
    Hepatology; 2016 Jul; 64(1):161-74. PubMed ID: 26926206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport.
    Paulusma CC; Groen A; Kunne C; Ho-Mok KS; Spijkerboer AL; Rudi de Waart D; Hoek FJ; Vreeling H; Hoeben KA; van Marle J; Pawlikowska L; Bull LN; Hofmann AF; Knisely AS; Oude Elferink RP
    Hepatology; 2006 Jul; 44(1):195-204. PubMed ID: 16799980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid flippase activities and substrate specificities of human type IV P-type ATPases localized to the plasma membrane.
    Takatsu H; Tanaka G; Segawa K; Suzuki J; Nagata S; Nakayama K; Shin HW
    J Biol Chem; 2014 Nov; 289(48):33543-56. PubMed ID: 25315773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive familial intrahepatic cholestasis type 1.
    Paulusma CC; Elferink RP; Jansen PL
    Semin Liver Dis; 2010 May; 30(2):117-24. PubMed ID: 20422494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of progressive familial intrahepatic cholestasis type 1 and benign recurrent intrahepatic cholestasis type 1 mutations on canalicular localization of ATP8B1.
    Folmer DE; van der Mark VA; Ho-Mok KS; Oude Elferink RP; Paulusma CC
    Hepatology; 2009 Nov; 50(5):1597-605. PubMed ID: 19731236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrates of P4-ATPases: beyond aminophospholipids (phosphatidylserine and phosphatidylethanolamine).
    Shin HW; Takatsu H
    FASEB J; 2019 Mar; 33(3):3087-3096. PubMed ID: 30509129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lipid flippase heterodimer ATP8B1-CDC50A is essential for surface expression of the apical sodium-dependent bile acid transporter (SLC10A2/ASBT) in intestinal Caco-2 cells.
    van der Mark VA; de Waart DR; Ho-Mok KS; Tabbers MM; Voogt HW; Oude Elferink RP; Knisely AS; Paulusma CC
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2378-86. PubMed ID: 25239307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A flippase-independent function of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1, is required for apical protein expression and microvillus formation in polarized epithelial cells.
    Verhulst PM; van der Velden LM; Oorschot V; van Faassen EE; Klumperman J; Houwen RH; Pomorski TG; Holthuis JC; Klomp LW
    Hepatology; 2010 Jun; 51(6):2049-60. PubMed ID: 20512993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
    Cai SY; Gautam S; Nguyen T; Soroka CJ; Rahner C; Boyer JL
    Gastroenterology; 2009 Mar; 136(3):1060-9. PubMed ID: 19027009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Tmem30a Deficiency Causes Intrahepatic Cholestasis by Impairing Expression and Localization of Bile Salt Transporters.
    Liu L; Zhang L; Zhang L; Yang F; Zhu X; Lu Z; Yang Y; Lu H; Feng L; Wang Z; Chen H; Yan S; Wang L; Ju Z; Jin H; Zhu X
    Am J Pathol; 2017 Dec; 187(12):2775-2787. PubMed ID: 28919113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity.
    Groen A; Romero MR; Kunne C; Hoosdally SJ; Dixon PH; Wooding C; Williamson C; Seppen J; Van den Oever K; Mok KS; Paulusma CC; Linton KJ; Oude Elferink RP
    Gastroenterology; 2011 Nov; 141(5):1927-37.e1-4. PubMed ID: 21820390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoinhibition and regulation by phosphoinositides of ATP8B1, a human lipid flippase associated with intrahepatic cholestatic disorders.
    Dieudonné T; Herrera SA; Laursen MJ; Lejeune M; Stock C; Slimani K; Jaxel C; Lyons JA; Montigny C; Pomorski TG; Nissen P; Lenoir G
    Elife; 2022 Apr; 11():. PubMed ID: 35416773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canalicular ABC transporters and liver disease.
    Nicolaou M; Andress EJ; Zolnerciks JK; Dixon PH; Williamson C; Linton KJ
    J Pathol; 2012 Jan; 226(2):300-15. PubMed ID: 21984474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P4 ATPases - lipid flippases and their role in disease.
    Folmer DE; Elferink RP; Paulusma CC
    Biochim Biophys Acta; 2009 Jul; 1791(7):628-35. PubMed ID: 19254779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content.
    Paulusma CC; de Waart DR; Kunne C; Mok KS; Elferink RP
    J Biol Chem; 2009 Apr; 284(15):9947-54. PubMed ID: 19228692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FIC1 disease: a spectrum of intrahepatic cholestatic disorders.
    van Mil SW; Klomp LW; Bull LN; Houwen RH
    Semin Liver Dis; 2001 Nov; 21(4):535-44. PubMed ID: 11745041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P4 ATPases: flippases in health and disease.
    van der Mark VA; Elferink RP; Paulusma CC
    Int J Mol Sci; 2013 Apr; 14(4):7897-922. PubMed ID: 23579954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and future therapies for inherited cholestatic liver diseases.
    van der Woerd WL; Houwen RH; van de Graaf SF
    World J Gastroenterol; 2017 Feb; 23(5):763-775. PubMed ID: 28223721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.